 Abcam PLC shares rose on Monday as the research tools maker said it had struck a deal to acquire BioVision Inc, a subsidiary of chemicals firm Chinese firm NKY Medical Holdings, for US340mln in cash. BioVision distributes research tools and has a strength in the assay kits market, Abcam said, adding that the purchase will bring one of its large third-party suppliers in-house. 